EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention

Jinghua An iD, Jeanne M Ferrante, Myneka Macenat, Shridar Ganesan, Shawna V Hudson, Coral Omene, Harold Garcia, Anita Y Kinney

Cancer · 2024

DOI: 10.1002/cncr.35049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Jinghua An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Black or African American, Clinical Trials as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Pfizer Global Medical Grants, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Black patients with cancer are less likely to receive precision cancer treatments than White patients and are underrepresented in clinical trials. To address these disparities, the study aimed to develop and pilot‐test a digital intervention to improve Black patients’ knowledge about precision oncology and clinical trials, empower patients to increase relevant discussion, and promote informed decision‐making.

Methods

A community‐engaged approach, including a Community Advisory Board and two rounds of key informant interviews with Black patients with cancer, their relatives, and providers ( n = 48) was used to develop and refine the multimedia digital intervention. Thematic analysis was conducted for qualitative data. The intervention was then pilot‐tested with 30 Black patients with cancer to assess feasibility, acceptability, appropriateness, knowledge, decision self‐efficacy, and patient empowerment; Wilcoxon matched pairs signed‐rank test was used to analyze quantitative data.

Results

The digital tool was found to be feasible, acceptable, and culturally appropriate. Key informants shared their preferences and recommendations for the digital intervention and helped improve cultural appropriateness through user and usability testing. In the pilot test, appreciable improvement was found in participants’ knowledge about precision oncology (z = –2.04, p = .052), knowledge about clinical trials (z = –3.14, p = .001), and decisional self‐efficacy for targeted/immune therapy (z = –1.96, p = .0495).

Conclusions

The digital intervention could be a promising interactive decision‐support tool for increasing Black patients’ participation in clinical trials and receipt of precision treatments, including immunotherapy. Its use in clinical practice may reduce disparities in oncology care and research. Plain Language Summary We developed a digital interactive decision support tool for Black patients with cancer by convening a Community Advisory Board and conducting interviews with Black patients with cancer, their relatives, and providers. We then pilot‐tested the intervention with newly diagnosed Black patients with cancer and found appreciable improvement in participants’ knowledge about precision oncology, knowledge about clinical trials, and confidence in making decisions for targeted/immune therapy. Our digital tool has great potential to be an affordable and scalable solution for empowering and educating Black patients with cancer to help them make informed decisions about precision oncology and clinical trials and ultimately reducing racial disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPrecision MedicineBlack or African AmericanClinical Trials as TopicPatient ParticipationHumansPilot ProjectsFemaleMaleMiddle AgedAdultAgedDecision MakingHealth Knowledge, Attitudes, PracticeMedical Oncology

Stichwörter der Autor:innen

chatbotclinical trial participationdecision‐makingdigital interventionimmunotherapyprecision medicinetargeted therapy

Autor:innen und Institutionen

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
  • Lawrence Herbert School of Communication, Hofstra University, Hempstead, New York, USA.
  • School of Public Health, The State University of New Jersey, New Brunswick, New Jersey, USA.

ORCID-Profile: Jinghua An

Förderung

  • NCI NIH HHS
  • Pfizer Global Medical Grants
  • National Cancer Institute

Zitieren

APA

An, J., Ferrante, J. M., Macenat, M., Ganesan, S., Hudson, S. V., Omene, C., Garcia, H., & Kinney, A. Y. (2024). Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention. Cancer. https://doi.org/10.1002/cncr.35049

Vancouver

An J, Ferrante JM, Macenat M, Ganesan S, Hudson SV, Omene C, et al. Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention. Cancer. 2024. doi:10.1002/cncr.35049

BibTeX
@article{An2024,
  author = {An, Jinghua and Ferrante, Jeanne M and Macenat, Myneka and Ganesan, Shridar and Hudson, Shawna V and Omene, Coral and Garcia, Harold and Kinney, Anita Y},
  title = {Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35049}
}
Kostenlos starten →